Article Text


A7.21 Suppression of HDAC5 Expression by Inflammatory Cytokines is Required to Promote CXCL Chemokine Production in RA FLS
  1. C Angiolilli1,
  2. AM Grabiec1,
  3. LGM van Baarsen1,
  4. PP Tak1,2,
  5. DL Baeten1,
  6. KA Reedquist1
  1. 1Department of Experimental Immunology and Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  2. 2Currently also: GlaxoSmithKline, Stevenage, UK


Background and Objectives Histone deacetylases (HDACs) are important regulators of gene expression and protein function in the immune system. HDAC inhibitors (HDACi) display anti-inflammatory properties in animal and in vitro models of rheumatoid arthritis (RA), as well as initial safety and efficacy in the treatment of systemic onset juvenile idiopathic arthritis. However, as most of the currently available HDACi display little selectivity or specificity for class I (HDAC 1–3, 8) and class II (HDAC 4–6, 9, 10) HDACs, the role of specific HDACs in RA is unclear. Here we examined the relationship between HDACs and inflammation in RA synovial tissue and fibroblast-like synoviocytes (FLS).

Materials and Methods RNA was isolated from arthroscopic synovial biopsies from 19 RA patients. MMP-1, TNFα, IL-6, and HDAC 1–10 expression was measured by quantitative PCR (qPCR). RA FLS were stimulated with IL-1β, TNFα and LP, S and HDAC expression was measured by qPCR RA FLS were transduced with adenovirus encoding control GFP or GFP-HDAC5 or transfected with control siRNA or siRNA targeting HDAC5. Effects of HDAC5 modulation on RA FLS gene expression were analysed by custom qPCR array.

Results Positive correlations were observed between RA synovial tissue expression of TNFα and HDAC1 (R = 0.651, P = 0.003) HDAC2 (R = 0.523, P = 0.022) and HDAC3 (R = 0.570, P = 0.011) and between MMP-1 and HDAC1 (R = 0.501, P = 0.029) and HDAC2 (R = 0.512, P = 0.025). A significant negative correlation was observed between synovial tissue expression of IL-6 and HDAC5 (R = –0.477, P = 0.039) and between clinical parameters of disease activity and HDAC5 (CRP: R = –0.664, P = 0.007; ESR: R = –0.556, P = 0.013: DAS28: R = –0.567, P = 0.011). HDAC5 mRNA expression was significantly and selectively reduced after RA FLS stimulation with TNFα and IL-1β, but not LPS. Of 84 genes regulated in RA FLS by IL-1β or TNFα, mRNA expression of CXCL9, CXCL10, and CXCL11 was selectively upregulated following silencing of HDAC5 expression. Conversely, mRNA expression of these chemokines was suppressed by overexpression of HDAC5 in RA FLS.

Conclusions RA synovial expression of HDAC 1 and 2, but not class II HDACs, positively correlates with local inflammatory mediators, while HDAC5 expression negatively correlates with IL-6 mRNA expression and with disease activity. HDAC5 mRNA is decreased after inflammatory stimulation, and silencing of HDAC5 leads to an increase of CXCL chemokine expression in RA. FLS, an effect reversed by HDAC5 overexpression. Our results suggest a protective role for HDAC5 in RA, and that HDACi which fail to target HDAC5 may be more promising for therapeutic applications.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.